Search:
All Dates (UTC+8):
  • All
  • 2025-06-06 [Friday]
  • 2025-06-07 [Saturday]
  • 2025-06-08 [Sunday]
All Rooms:
  • All
  • Watson Auditorium
  • Exhibition Area II
  • Exhibition Area III
  • Meeting Room M1
  • Meeting Room F1
  • Meeting Room M2
  • Meeting Room M6
  • Meeting Room M4

2025-06-06 Friday

Exhibition Area II (UTC+8)

14:00-15:00 (UTC+8) | Executive Master of Interventional Radiology (EMIR) - I
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:00-14:07

Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE after Biliary Drainage: TEMP Score

Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China
2 14:07-14:14

Thermosensitive Nanogel: A Novel Embolic Agent of TACE for HCC

Rong Ding Yunnan Provincial Cancer Hospital, China
3 14:14-14:21

Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced HCC Patients Receiving TACE plus Systemic Therapies

Jin-Feng Bai Yunnan Provincial Cancer Hospital, China
4 14:21-14:28

TACE Combined with Systemic Therapy for Unresectable Liver Cancer

Ning Ai The Fourth Hospital of Hebei Medical University, China
5 14:28-14:35

TACE and TKIs with or without PD-1 as First-line Treatment for Unresectable HCC: A Propensity Score Matching Study

Xue-Gang Yang Sichuan Cancer Hospital & Institute, China
6 14:35-14:42

MWA vs. RFA Combined with Vertebroplasty for Vertebral Metastatic Tumors: A Retrospective Cohort Study

Fu-An Wang Jiangsu Subei People's Hospital, China
7 14:42-15:00

Panelists

Hai-Dong Zhu Zhongda Hospital, Southeast University, China / Alex Tang Subang Jaya Medical Centre,Malaysia / Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China / Rong Ding Yunnan Provincial Cancer Hospital, China / Jin-Feng Bai Yunnan Provincial Cancer Hospital, China / Ning Ai The Fourth Hospital of Hebei Medical University, China / Xue-Gang Yang Sichuan Cancer Hospital & Institute, China / Fu-An Wang Jiangsu Subei People's Hospital, China / Jian-Bo Zhao Southern Hospital of Southern Medical University, China
15:00-16:00 (UTC+8) | Executive Master of Interventional Radiology (EMIR) - II
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 15:00-15:07

Fruquintinib Combined with Sintilimab plus TACE for Unresectable HCC: A Single-arm Phase 2 Study

Hui Zeng Zhejiang Provincial Cancer Hospital, China
2 15:07-15:14

Predictive Model of Unresectable HCC Treated with TACE-HAIC Combined with TKIs and ICIs

Li-Nan Yin Harbin Medical Univisity Cancer Hospital, China
3 15:14-15:21

Transformation of IR Workflow through Smart Operating Room Development: Technological Integration and Clinical Practice

Lin Zhu Zhongshan Hospital Affiliated with Fudan University, China
4 15:21-15:28

Can Commonly Used Large Language Models Be Recommend Interventional Therapy to Liver Cancer Patients?

Zhi-Hui Chang Shengjing Hospital of China Medical University, China
5 15:28-15:35

Association between TACE Refractoriness and Prognosis in Chinese Patients with HCC: A Retrospective Cohort Study

Qin-Xue Sun Ningbo Medical Center Li Huili Hospital, China
6 15:35-16:00

Panelists

Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea / Prijo Sidipratomo Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia / Hui Zeng Zhejiang Provincial Cancer Hospital, China / Li-Nan Yin Harbin Medical Univisity Cancer Hospital, China / Lin Zhu Zhongshan Hospital Affiliated with Fudan University, China / Zhi-Hui Chang Shengjing Hospital of China Medical University, China / Qin-Xue Sun Ningbo Medical Center Li Huili Hospital, China
16:00-18:00 (UTC+8) | Passing the Torch Mentoring Program
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:10

Passing the Torch Mentoring Program: Introduction

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
2 16:10-16:20

Passing the Torch Mentoring Program: Leading Mission I

Hang Yuan Henan Cancer Hospital, China
3 16:20-16:30

Passing the Torch Mentoring Program: Leading Mission II

Bing-Jie Zheng Henan Cancer Hospital, China
4 16:30-16:40

Passing the Torch Mentoring Program: Leading Mission IIIa

Hang Yuan Henan Cancer Hospital, China
5 16:40-16:50

Passing the Torch Mentoring Program: Leading Mission IIIb

Shi-Jun Xu Henan Cancer Hospital, China
6 16:50-17:00

Passing the Torch Mentoring Program: Leading Mission IV

Hong-Tao Hu Henan Cancer Hospital, China
7 17:00-17:10

Passing the Torch Mentoring Program: Leading Mission V

Xi Li The Fifth Affiliated Hospital of Sun Yat-sen University, China
8 17:10-17:20

Passing the Torch Mentoring Program: Leading Mission VI

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
9 17:20-18:00

Q & A and Panel Discussion (Overcoming Miscommunication & Shaping the Future)

Jiaywei Tsauo Guangdong Provincial People's Hospital, China / Bin-Yan Zhong Zhejiang Cancer Hospital, China

Exhibition Area III (UTC+8)

14:00-16:00 (UTC+8) | Pathways to Publication: Scientific Writing Skills
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:00-14:30

How to Get Your Paper Published

Jiaywei Tsauo Guangdong Provincial People's Hospital, China
2 14:30-14:45

The Art of Transforming Ideas into Scientific Investigations

Bin-Yan Zhong Zhejiang Cancer Hospital, China
3 14:45-15:00

How I Updated My Writing Skills after Publishing My First Paper

Chu-Hui Zeng Zhongda Hospital, Southeast University, China
4 15:00-15:15

Top Five Reasons for Writing Scientific Papers

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
5 15:15-15:55

Panelist

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China / Jiaywei Tsauo Guangdong Provincial People's Hospital, China / Chu-Hui Zeng Zhongda Hospital, Southeast University, China / Bin-Yan Zhong Zhejiang Cancer Hospital, China / Jian Lu Zhongda Hospital, Southeast University, China / Xi Li The Fifth Affiliated Hospital of Sun Yat-sen University, China
16:00-17:30 (UTC+8) | To Treat or Not to Treat: Debating Local Treatments for Portal Vein Tumour Thrombosis
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:12

Sequential TACE and PVE before Right Pemihepatectomy in Patients with HCC

Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea
2 16:12-16:24

Surgical Treatment of HCC with Portal Vein Tumor Thrombus - Progress and Perspectives

Shu-Qun Cheng Eastern Hepatobiliary Surgery Hospital, China
3 16:24-16:36

TARE for Unresected HCC with Portal Vein Invasion: Which Patient to Treat?

Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India
4 16:36-16:48

Precision Radiotherapy and Immune-targeted Therapeutic Strategies in Hepatocellular Carcinoma

Wei-Hu Wang Beijing Cancer Hospital, China
5 16:48-17:00

ICIs and Anti-VEGF Antibody/TKIs with or without TACE as First-line Treatment for Advanced HCC (CHANCE2201): A Target Trial Emulation Study

Hai-Tao Zhao Peking Union Medical College Hospital, China
6 17:00-17:12

A Nationwide Target Trial Emulation on the Treatment of Patients with HCC and Main Trunk PVTT Using 125I Irradiation Stents and Combined Therapeutic Approaches (PATENCY II)

Jian Lu Zhongda Hospital, Southeast University, China
7 17:12-17:30

Panelists

Flavio G. Rocha Oregon Health and Science University, USA / Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea / Shu-Qun Cheng Eastern Hepatobiliary Surgery Hospital, China / Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India / Wei-Hu Wang Beijing Cancer Hospital, China / Hai-Tao Zhao Peking Union Medical College Hospital, China / Jian Lu Zhongda Hospital, Southeast University, China

Meeting Room M1 (UTC+8)

14:00-15:15 (UTC+8) | Pathways to Publication: Connect with EngMedicine
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:00-14:05

Opening Remarks

Gao-Jun Teng Zhongda Hospital, Southeast University, China
2 14:05-14:20

NEJM and Clinical Research

Rui-Ping Xiao Associate Editor, New England Journal of Medicine, China
3 14:20-14:35

Why and How to Publish on Med-X Journal?

Lisa X. Xu Editors-in-Chief, Med-X, China
4 14:35-14:50

Trends and Prospects of Sustainable Growth in STTT

Qiu Sun Editor, Signal Transduction and Targeted Therapy, China
5 14:50-15:05

The Innovation Journals: Serving Global Reserchers

Ke Chen Executive Director, The Innovation, China
6 15:05-15:15

Introduction to EngMedicine

Fu-Gen Wu Southeast University, China
17:00-18:00 (UTC+8) | ISMIO Committee Meeting

Meeting Room M2 (UTC+8)

13:30-15:00 (UTC+8) | Your Efforts Matter - I
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:36

The Value of 40 KeV Virtual Monoenergetic Imaging in Preoperative Assessment for Precision TACE in Hepatocellular Carcinoma

Shuang Li Zhongda Hospital, Southeast University, China
2 13:36-13:42

Efficacy and Safety of Adebrelimab (A PD-L1 Inhibitor) plus Bevacizumab (A VEGF-A-targeting Inhibitor) in Combination with Hepatic Artery Infusion Chemotherapy for Advanced Stage Hepatocellular Carcinoma: A Retrospective Cohort Study

Chen Li Sun Yat-sen University Cancer Center, China
3 13:42-13:48

A Comparison of Treatment Outcome of Hepatocellular Carcinoma in Caudate Lobe, between Thermal Ablation and Transarterial Chemoembolization: A Retrospective Review

Sahutchadech Tangisarapap Roi-Et hospital, Thailand
4 13:48-13:54

Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Gallbladder

Batmunkh Erdenebulgan Second state central hospital, Mongolia
5 13:54-14:00

Percutaneous Cholangioscopy and Fluoroscopy-guided Forceps Biopsy for Pathologically Diagnosing Highly Suspected Perihilar Malignant Diseases: A Retrospective Cohort Study

Xiang-Yu Yang Beijing Chao-Yang Hospital, Capital Medical University, China
6 14:00-14:06

A Prospective, Single-Arm, Phase 2 Study of Transarterial Embolization plus Hepatic Arterial Infusion Chemotherapy Combined with Sequential Lenvatinib and Sintilimab in Patients with Infiltrative Hepatocellular Carcinoma.

Ying-Wen Hou Sun Yat-sen University Cancer Center, China
7 14:06-14:12

Efficacy and Safety of TACE Combined with TKI against TACE Alone for Managing Intermediate-stage HCC with Hypovascular Nodules

Jun Yang The First Affiliated Hospital of Soochow University, China
8 14:12-14:18

First-line Durvalumab with Arterial Chemotherapy in Major Portal Invaded Hepatocellular Carcinoma: the Phase 2 DurHope Study with Biomolecular Analyses

Ming Zhao Sun Yat-sen Cancer Center, China
9 14:18-14:24

The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for Liver Tumours after Image-guided Irreversible Electroporation

Vinson Chan University of Leeds, United Kingdom
10 14:24-14:30

Early Response Evaluation of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Triphasic Computed Tomography

Nasr ullah Yaqoob INDUS HOSPITAL KARACHI PAKISTAN, Pakistan
11 14:30-14:36

Transarterial Chemoembolization plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-risk Locations

Guilin Zhang Wuhan Union Hospital, Huazhong University of Science and Technology, China
12 14:36-14:42

Hepatic Arterial Infusion Chemotherapy Combined with Toripalimab and Surufatinib in the Treatment of Advanced Intrahepatic Cholangiocarcinoma

Songlin Song Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China
13 14:42-14:48

Complications of Interventional Treatment for Vascular Tumors and Vascular Malformations: Mechanisms of Occurrence, Treatment Strategies and Prevention

Qi Wang Guangdong Provincial People's Hospital, China
15:00-16:30 (UTC+8) | Your Efforts Matter - II
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 15:00-15:06

TACE Combined with Immunotherapy plus Targeted Therapy after 125I Irradiation Stent Placement in HCC with Main Portal Vein Tumor Thrombosis: A Nationwide Target Trial Emulation Study (PATENCY II)

Jun-Hao Mei Zhongda Hosiptal, China
2 15:06-15:12

Development and Validation of Mean Platelet Volume-Based Predictive Model for Early TACE Failure/Refractoriness in Unresectable Hepatocellular Carcinoma: A Real-World Retrospective Cohort Study

Hai-Rui Wang Shengjing Hospital of China Medical University, China
3 15:12-15:18

Optimal Thermal Ablation Margin Range Model for Liver Malignancies ≤3 cm Based on 979 Cases

Zhen-Kang Qiu Sun Yat-sen University Cancer Center, China
4 15:18-15:24

Locoregional Therapy Combined with Systemic Therapy (LRT + ST) for Unresectable and Metastatic Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-analysis

Zhen-Kang Qiu Sun Yat-sen University Cancer Center, China
5 15:24-15:30

Successful Preoperative Transcatheter Arterial Embolization Significantly Reduces Intraoperative Bleeding in Juvenile Nasopharyngeal Angiofibroma without the Need for Embolization of Internal Carotid Artery Branches: A Case Report of Two Patients

Stephen Kurniawan Dr. Cipto Mangunkusumo Hospital-Faculty of Medicine Universitas Indonesia
6 15:30-15:36

Lenvatinib plus Hepatic Arterial Infusion Chemotherapy of FOLFOX versus Lenvatinib Alone for Advanced Hepatocellular Carcinoma

Qi-Cong Mai Guangdong Provincial People's Hospital, China
7 15:36-15:42

Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma : A Bibliometric and Knowledge-map Analysis

Yu-Qing Xu Tianjin Medical University Cancer Institute & Hospital,National Clinical Research Center for Cancer, China
8 15:42-15:48

Study on the Role of Pirfenidone in Liver Fibrosis - Hepatocellular Carcinoma

Shuai Zhang The Affiliated Hospital of Guizhou Medical, China
9 15:48-15:54

Hyaluronidase Additional to Transarterial Chemoembolization Improves Efficacy for Liver Cancer: Preclinical Evaluation

Dan Zhao Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
10 15:54-16:00

Transarterial Chemoembolisation and Tyrosine Kinase Inhibitors with or without Programmed Death-1 Inhibitors as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study

Xue-Gang Yang Sichuan Cancer Hospital & Institute, China
11 16:00-16:06

Temperature‑sensitive Liquid Embolic Agent Transarterial Chemoembolization (TempSLE-TACE) versus D-TACE for Unresectable Hepatocellular Carcinoma(u-HCC): A Multicenter Retrospective Propensity Score Study in China

Qingyun Xie Liver Transplantation Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, China
12 16:06-16:12

Superselective Ablative Chemo-ethanol Embolization for Recurrent Single Hepatocellular Carcinoma

Kun Yung Kim Seoul National University Bundang Hospital, Korea
13 16:12-16:18

Efficacy and Prognostic Factors of COVID-19 Vaccine in Patients with Hepatocellular Carcinoma: Analysis of Data from A Prospective Cohort Study

He Zhao National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
14 16:18-16:24

HAIC Combined with Sindilizumab and Bevacizumab for the Treatment of Advanced HCC: An Exploratory Clinical Study

Zizhuo Wang Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China
15 16:24-16:30

Integrated Machine Learning Identifies SPP1hi Macrophages Marker Genes for Predicting Therapeutic Response of TACE in HCC

Zi-Lin Wang Zhejiang University School of Medicine, China
16:30-18:00 (UTC+8) | Your Efforts Matter - III
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:30-16:36

Fruquintinib Combined with Sintilimab plus Transarterial Chemoembolization (TACE) for Unresectable Hepatocellular Carcinoma (uHCC): A Single-arm Phase Ⅱ Study

Hui Zeng Zhejiang Provincial Cancer Hospital, China
2 16:36-16:42

Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced Hepatocellular Carcinoma Patients Receiving TACE Combined with Systemic Therapies

Jin-Feng Bai Yunnan Provincial Cancer Hospital, China
3 16:42-16:48

Revolutionizing Detection and Ablation of Invisible Liver Metastases Post-Chemotherapy in Colorectal Cancer: the Role of Transcatheter CT Hepatic Arteriography

Hang Yuan Henan Cancer Hospital, China
4 16:48-16:54

Yttrium-90 Radioactive Microspheres: Adverse Reactions and Complications of Transcatheter Arterial Radioembolization in the Treatment of Malignant Liver Tumors

Meng-Di Qi China Medical University, China
5 16:54-17:00

A Study on the Contribution of LSM11 to the Outcome of Radiotherapy in Hepatocellular Carcinoma Cells

Wen-Yi Jiang Peking University Cancer Hospital, China
6 17:00-17:06

Safety and Technical Feasibility of Modified Percutaneous Transesophageal Enterostomy (PTEE) in Cancer Patients Ineligible for Conventional Gastrostomy

Ji Hoon Shin Asan Medical Cente, University of Ulsan College of Medicine, Korea
7 17:06-17:12

In Which Tumor Burden Range Does Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Perform Better than the Combination of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors? A Comparative Analysis of Their Efficacy and Safety in Advanced-stage Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus, Using Propensity Score Matching

Jia-Xi Liu The First Hospital of China Medical University, China
8 17:12-17:18

Combined Biliary Iodine-125 Brachytherapy and Stent Implantation in Malignant Obstructive Jaundice: A Prognostic Model for Survival Outcomes

Hui-Yi sun Interventional Therapy at Zhongshan Hospital, Fudan University, China
9 17:18-17:24

CT-guided Celiac Plexus Neurolysis in the Management of Visceral Intractable Pain in Patients with Advanced Cancer

Tai Tan Nguyen Nhan Dan Gia Dinh Hospital, Vietnam
10 17:24-17:30

Radioactive Iodine-125 Particle Implantation Combined with Transarterial Chemoinfusion and Synchronous Immune Checkpoint Inhibitors for the Management of Locally Advanced Pancreatic Cancer: A Retrospective Single-center Analysis

Bin Li Beijing Hospital, China
11 17:30-17:36

CT-guided Percutaneous Cryoablation in Patients with Lung Nodules Mainly Composed of Ground-Glass Opacities

Li-Zhi Niu Guangzhou Fuda Cancer Hospital, China
12 17:36-17:42

The Effect and Mechanism of Iodine 125 Seeds in Combination with Curcumin in Non-Small Cell Lung Cancer

Zi-Tong Chen Children's Hospital Alfiliated to Shandong University, China
13 17:42-17:48

Ablative Therapy for Residual Lesions After First-Line Treatment of Locally Advanced Unresectable Lung Adenocarcinoma: A Prospective, Randomized Controlled Study

Feng Xian Sichuan Cancer Hospital, China

2025-06-07 Saturday

Watson Auditorium (UTC+8)

08:00-09:00 (UTC+8) | Plenary Lecture
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 08:00-08:20

Precision Treatment of Triple Negative Breast Cancer

Zhi-Min Shao Fudan University Affiliated Cancer Hospital, China
2 08:20-08:40

Use of Artificial Intelligence for Imaging and Therapy of HCC

Julius Chapiro Yale School of Medicine, USA
3 08:40-09:00

Application of Ultra Resolution Microscopy in Tumor Diagnosis and Treatment

Ping Liang Chinese PLA General Hospital, China
09:00-09:30 (UTC+8) | Opening Ceremony
09:30-10:00 (UTC+8) | Gui Lin & Zi-Jiang Liu Lecture
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 09:35-09:55

Gastroduodenal Stents: Evolution and Future Perspectives

Ho-Young Song Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China
10:00-12:00 (UTC+8) | Keynote Speech
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 10:00-10:20

Advancement of Combined Locoregional Therapy with Immunotherapy in HCC

Gao-Jun Teng Zhongda Hospital, Southeast University, China
2 10:20-10:40

New Horizons of Liver Tumor Treatment

David C. Madoff Yale School of Medicine, USA
3 10:40-11:00

Multimodal Thermal Therapy for Solid Tumor: A New Interventional Immunomodulatory

Lisa X. Xu Shanghai Jiao Tong University, China
4 11:00-11:20

Preclinical and Clinical Histotripsy for the Treatment of Liver Cancer

Maggie (Man) Zhang University of Michigan, USA
5 11:20-11:40

Research on the Mechanisms of Cancer Cachexia and Drug Development

Rui-Ping Xiao Peking University, China
6 11:40-12:00

Discussion

Exhibition Area II (UTC+8)

12:30-13:30 (UTC+8) | President's Luncheon
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 12:30-12:35

Opening Remarks

Gao-Jun Teng Zhongda Hospital, Southeast University, China
2 12:35-12:40

Experts Speech

Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China / Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China / Hua Xiang Hunan Cancer Hospital, China / Guo-Hong Han Xi'an International Medical Center Hospital, China / Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
3 12:40-12:55

Structured Research, Limitless Innovation

Masatoshi Kudo Kindai University Faculty of Medicine, Japan
4 12:55-13:10

laparoscopic liver resection for liver cance

Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China
5 13:10-13:25

Panelists

Masatoshi Kudo Kindai University Faculty of Medicine, Japan / Tian-Qiang Song Tianjin Medical University Cancer Institute & Hospital, China / Hai-Tao Zhao Peking Union Medical College Hospital, China / Hai-Bo Shao The First Affiliated Hospital of China Meical University, China / Jia-Ping Li The First Affiliated Hospital of Sun Yat-sen University, China / Ming Zhao Sun Yat-Sen University Cancer Center, China / Hai-Peng Yu Tianjin Medical University Cancer Institute & Hospital, China / Jian Lu Zhongda Hospital, Southeast University, China / Bin-Yan Zhong Zhejiang Cancer Hospital, China / Wen-Zhe Fan The First Affiliated Hospital, Sun Yat-Sen University, China
6 13:25-13:30

Summary

Gao-Jun Teng Zhongda Hospital, Southeast University, China
13:30-14:30 (UTC+8) | Intersections: Evidence-Based Strategy for Curing Hepatocellular Carcinoma
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:42

Role of Y90 Radioembolization in Treatment of Large HCCs

Rickie Lik-Fai Cheng Princess Margaret Hospital, Hong Kong, China
2 13:42-13:54

Combination of TACE with Systemic Therapy for Unresectable HCC

Zhen-Wei Peng The First Affiliated Hospital, Sun Yat-Sen University, China
3 13:54-14:06

Advanced Forearm Access for Same Day Radiation Segmentectomy

Uei Pua Tan Tock Seng Hospital, Singapore
4 14:06-14:18

How to Provide More Surgical Opportunities for Patients with HCC Using Minimal Invasive Methods to Increase the Remnant Liver Volume

Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China
5 14:18-14:30

Panelists

Tao Peng The First Affiliated Hospital of Guangxi Medical University, China / Ji Hoon Shin Asan Medical Cente, University of Ulsan College of Medicine, Korea / Rickie Lik-Fai Cheng Princess Margaret Hospital, Hong Kong, China / Zhen-Wei Peng The First Affiliated Hospital, Sun Yat-Sen University, China / Uei Pua Tan Tock Seng Hospital, Singapore / Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China
14:30-15:30 (UTC+8) | Interventional Oncology and Immuno-oncology for Hepatocellular Carcinoma
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:30-14:42

Combining TACE with Checkpoint Inhibitors for Intermediate-stage HCC

David C. Madoff Yale School of Medicine, USA
2 14:42-14:54

How to Select 2nd-line Systemic Therapy in Advanced-stage HCC?

Masatoshi Kudo Kindai University Faculty of Medicine, Japan
3 14:54-15:06

First-line TACE with ICIs and VEGF or TKIs for Intermediate-stage HCC: A Target Trial Emulation Study

Hai-Dong Zhu Zhongda Hospital, Southeast University, China
4 15:06-15:18

Is Systemic Therapy Alone Sufficient as Standard Treatment for Advanced Stage HCC?

Xiao-Dong Wang Beijing Cancer Hospital, China
5 15:18-15:30

Panelists

Wan-Guang Zhang Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China / David C. Madoff Yale School of Medicine, USA / Masatoshi Kudo Kindai University Faculty of Medicine, Japan / Hai-Dong Zhu Zhongda Hospital, Southeast University, China / Xiao-Dong Wang Beijing Cancer Hospital, China
16:00-17:00 (UTC+8) | A Forward March: Updates in Cholangiocarcinoma
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:12

Hepatopancreatoduodenectomy for Widespread Hilar Cholangiocarcinoma

Kiyoshi Hasegawa Graduate School of Medicine, The University of Tokyo Hospital, Japan
2 16:12-16:24

Surgical and Multidisciplinary Treatment of Intrahepatic Cholangiocarcinoma

Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China
3 16:24-16:36

Intervention for Biliary Malignancy

Seung Boo Yang Nowon Eulji University Hospital, Korea
4 16:36-16:48

Neoadjuvant Therapy for BTC — A Medical Oncologist's Perspective

Yuan Cheng Jinling Hospital, Nanjing University, China
5 16:48-17:00

Panelists

Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China / Hai-Tao Zhao Peking Union Medical College Hospital, China / Kiyoshi Hasegawa Graduate School of Medicine, The University of Tokyo Hospital, Japan / Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China / Seung Boo Yang Nowon Eulji University Hospital, Korea / Yuan Cheng Jinling Hospital, Nanjing University, China
17:00-18:15 (UTC+8) | Driving Change in Diagnostic and Therapeutic Strategies
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 17:00-17:12

Percutaneous Biliary Metallic Stent Insertion in Patients with Malignant Duodenobiliary Obstruction: Outcomes and Factors Influencing Biliary Stent Patency

Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea
2 17:12-17:24

Research Progress and Challenges in Mucosal Melanoma of the Head and Neck

Wei Guo Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China
3 17:24-17:36

The Value of Integrated Angiography and CT Scan System for Oncologic Interventions

Kiang Hiong Tay Singapore General Hospital, Singapore
4 17:36-17:48

Same Day Percutaneous Renal Cryoablation : A New Paradigm to Enhancing Patient Care?

Jun-Jian Huang Emory University school of medicine, USA
5 17:48-18:00

Cool Approach, Clear Result: Lung Cryoablation in Clinical Practice

Somrach Thamtorawat Faculty of Medicine Siriraj Hospital, Thailand
6 18:00-18:15

Panelists

Alex Tang Subang Jaya Medical Centre,Malaysia / Wei-Qian Chen Zhejiang Lishui Central Hospital, China / Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea / Wei Guo Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China / Kiang Hiong Tay Singapore General Hospital, Singapore / Jun-Jian Huang Emory University school of medicine, USA / Somrach Thamtorawat Faculty of Medicine Siriraj Hospital, Thailand

Exhibition Area III (UTC+8)

12:30-13:30 (UTC+8) | Satellite Symposium - 2
13:30-14:30 (UTC+8) | Maximize the Effects of Lung Cancer Treatments
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:42

Trans-arterial Approach for Treatment of Primary Lung Cancer

Shinichi Hori Institute for Image Guided Therapy, Japan
2 13:42-13:54

Bronchial Artery Embolization in Hemoptysis: Is Glue Better than PVA?

Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India
3 13:54-14:06

Lung Neoplasms—the Role of TACP, TPCE Combined with Thermoablation: Long-term Evaluation

Thomas J. Vogl University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany
4 14:06-14:18

Current Status of Clinical Application of SBRT in Lung Tumors

Ya-Ping Xu Shanghai Pulmonary Hospital, China
5 14:18-14:30

Panelists

Xiao-Li Zhu The First Affiliated Hospital of Soochow University, China / Shinichi Hori Institute for Image Guided Therapy, Japan / Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India / Thomas J. Vogl University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany / Ya-Ping Xu Shanghai Pulmonary Hospital, China
14:30-15:45 (UTC+8) | Hybrid Theater: Optimize the Outcome of Breast Cancer
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:30-14:42

A New Field of Interventional Radiology: Breast Cancer Treatment

Shinichi Hori Institute for Image Guided Therapy, Japan
2 14:42-14:54

Translational Research in Breast Cancers Metabolism

Hai Hu Zhejiang Cancer Hospital, China
3 14:54-15:06

Evolution of Antibody-drug-conjugate Therapy for Breast Cancer

Masakazu Toi Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan
4 15:06-15:18

TBD

Yong-Mei Yin Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China
5 15:18-15:30

Advances in Breast Cancer Ablation

Jie Yu Chinese PLA General Hospital, China
6 15:30-15:45

Panelists

Yong-Mei Yin Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China / Hai-Peng Yu Tianjin Medical University Cancer Institute & Hospital, China / Hai Hu Zhejiang Cancer Hospital, China / Masakazu Toi Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan / Jie Yu Chinese PLA General Hospital, China
16:00-17:00 (UTC+8) | Current and Future Treatments for Pancreatic Cancer
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:12

Contemporary Management of Locally Advanced Pancreas Cancer

Flavio G. Rocha Oregon Health and Science University, USA
2 16:12-16:24

Precision Management of Pancreatic Cancer in the Era of Multimodal Analysis

Bai-Yong Shen Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
3 16:24-16:36

High-voltage Pulse Technology: From Fundamental Principles to Comprehensive Applications in Multiple Fields

Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
4 16:36-16:48

A Personalised Approach in the Treatment of Pancreatic Cancer

Alexey Zhao P. A. Herzen Institute of Oncology, Russia
5 16:48-17:00

Panelists

Govindarajan Narayanan Miami Cancer Institute Baptist Health South Florida, USA / Flavio G. Rocha Oregon Health and Science University, USA / Bai-Yong Shen Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China / Alexey Zhao P. A. Herzen Institute of Oncology, Russia / Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
17:00-18:15 (UTC+8) | Innovations: New Drugs, New Devices, and New Techniques - III
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 17:00-17:12

Clinical Outcomes of Ablation-osteoplasty-reinforcement-internal Fixation (AORIF) of the Peri-acetabular Metastases from Breast, Lung, Prostate, and Kidney

Francis Lee Yale School of Medicine, USA
2 17:12-17:24

AI-integrated PTA Treatment

Aichi Chien David Geffen School of Medicine at UCLA, USA
3 17:24-17:36

Tips and Tricks for Manipulation of Microcatheter

Shinichi Hori Institute for Image Guided Therapy, Japan
4 17:36-17:48

Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma: An Overview of Global Practices and Emerging Trends

Tamana Marvin Philippine Heart Center, Philippines
5 17:48-18:00

Technology-enhanced Precision in MIS HPB Surgery

Alfred Kow Wei Chieh National University Hospital, Singapore
6 18:00-18:15

Panelists

Song Wang The Affiliated Hospital of Qingdao University, China / Francis Lee Yale School of Medicine, USA / Gao-Feng Shu Zhejiang Lishui Central Hospital, China / Aichi Chien David Geffen School of Medicine at UCLA, USA / Shinichi Hori Institute for Image Guided Therapy, Japan / Tamana Marvin Philippine Heart Center, Philippines / Alfred Kow Wei Chieh National University Hospital, Singapore

Meeting Room M1 (UTC+8)

12:30-13:30 (UTC+8) | Satellite Symposium - 3
13:30-14:30 (UTC+8) | Breaking Barriers: Unlocking the Potential of Emerging Techniques for Malignancies
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:42

Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective

Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea
2 13:42-13:54

Value Based Care in IR Treatments of Hepatocellular Carcinoma

Kiang Hiong Tay Singapore General Hospital, Singapore
3 13:54-14:06

MRI-guided Clinically Bacteriplytic Transarterial Embolization for Liver Tumor Therapy

Zhuo-Li Zhang University of California, USA
4 14:06-14:18

Biomaterials to Assist Interventional Cancer Therapies

Zhuang Liu Soochow University, China
5 14:18-14:30

Panelists

Lei Zhang Sun Yat-sen Memorial Hospital, China / Hong-Shan Zhong China Medical University, China / Hyun Ki Yoon Asan Medical Center, University of Ulsan College of Medicine, Korea / Kiang Hiong Tay Singapore General Hospital, Singapore / Zhuo-Li Zhang University of California, USA / Zhuang Liu Soochow University, China
14:30-15:30 (UTC+8) | Redefining the Standard of Loco-regional Treatments for Malignancies
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:30-14:42

Development and Application of Early Screening and Diagnosis Technology for Gastric Cancer

Xiang-Dong Cheng Zhejiang Cancer Hospital, China
2 14:42-14:54

Advancing Y-90 Dosimetry: Personalized Approaches for Hepatocellular Carcinoma

Jon C. Davidson University Hospitals Cleveland Medical Center, USA
3 14:54-15:06

Surgical Resection with Major Hepatic Vein Reconstruction for Colorectal Liver Metastasis

Kiyoshi Hasegawa Graduate School of Medicine, The University of Tokyo Hospital, Japan
4 15:06-15:18

Ablation of Liver Cancer: Challenges and Developments

Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China
5 15:18-15:30

Panelists

Fei Gao Sun Yat-Sen University Cancer Center, China / Prijo Sidipratomo Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia / Xiang-Dong Cheng Zhejiang Cancer Hospital, China / Jon C. Davidson University Hospitals Cleveland Medical Center, USA / Wei-Ling He Xiamen University Affiliated Xiang'an Hospital, China / Kiyoshi Hasegawa Graduate School of Medicine, The University of Tokyo Hospital, Japan
16:00-17:00 (UTC+8) | Systemic Therapy: Challenges and Advances
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:12

Different Response Pattern between IO plus Anti-VEGF and IO plus IO Regimens

Masatoshi Kudo Kindai University Faculty of Medicine, Japan
2 16:12-16:24

Mechanistic Research and Emerging Therapeutic Approaches for Hepatocellular Carcinoma with Pulmonary Metastasis

Hong Wu West China Hospital of Sichuan University, China
3 16:24-16:36

Combining TACE with Checkpoint Inhibitors for Intermediate-Stage HCC

Jon C. Davidson University Hospitals Cleveland Medical Center, USA
4 16:36-16:48

Chinese Experience of Perioperative Management for Liver Cancer

Hong Zhao Cancer Institute and Hospital, China
5 16:48-17:00

Panelists

Hong Wu West China Hospital of Sichuan University, China / Le-Du Zhou Xiangya Hospital of Central South University, China / Masatoshi Kudo Kindai University Faculty of Medicine, Japan / Jon C. Davidson University Hospitals Cleveland Medical Center, USA / Hong Zhao Cancer Institute and Hospital, China
17:00-18:00 (UTC+8) | Ablation for Malignancies: What We Should Know and How I Do It
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 17:00-17:12

Multimodal Therapies and Emerging Insights in Colorectal Cancer Liver Metastases

Wei-Ling He Xiamen University Affiliated Xiang'an Hospital, China
2 17:12-17:24

Advancements in Irreversible Electroporation Techniques for Kidney Tumors

Tze Min Wah St. James's University Hospital, UK
3 17:24-17:36

The Evolution of Irreversible Electroporation: Insights from a Decade of Practice

Govindarajan Narayanan Miami Cancer Institute Baptist Health South Florida, USA
4 17:36-17:48

Microwave Ablation for Large Tumors: Techniques to Minimize Recurrence

Jon C. Davidson University Hospitals Cleveland Medical Center, USA
5 17:48-18:00

Panelists

Masakazu Toi Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan / Yong-Yi Zeng The First Affiliated Hospital of Fujian Medical University, China / Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China / Tze Min Wah St. James's University Hospital, UK / Govindarajan Narayanan Miami Cancer Institute Baptist Health South Florida, USA / Jon C. Davidson University Hospitals Cleveland Medical Center, USA

Meeting Room F1 (UTC+8)

12:30-13:30 (UTC+8) | Satellite Symposium - 4
13:30-14:30 (UTC+8) | Innovations: New Drugs, New Devices, and New Techniques - I
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:42

The Application of AI in HPB Surgery and Oncology

Alfred Kow Wei Chieh National University Hospital, Singapore
2 13:42-13:54

A Duo-targeting Pan-anticancer Strategy with Potential Interventional Applications

Yi-Cheng Ni Southeast University, China
3 13:54-14:06

New Data Showing Vascular Changes in Patients with Diabetes: How to Modify Treatment Strategies

Aichi Chien David Geffen School of Medicine at UCLA, USA
4 14:06-14:18

ALPPS--New Surgical Paradigm to Treat Traditionally-Unresectable Liver Cancer

Jian Zhou Zhongshan Hospital, Fudan University, China
5 14:18-14:30

Panelists

Guang-Hui Luo Kiang Wu Hospital, Macau, China / Han Wang Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China / Alfred Kow Wei Chieh National University Hospital, Singapore / Yi-Cheng Ni Southeast University, China / Aichi Chien David Geffen School of Medicine at UCLA, USA / Jian Zhou Zhongshan Hospital, Fudan University, China
14:30-15:45 (UTC+8) | Innovations: New Drugs, New Devices, and New Techniques - II
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:30-14:42

Lymphangiography and TD Embolization in Latrogenic Chylous Leaks

Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India
2 14:42-14:54

MRI-guided IRE Combined with DC Vaccination for PDAC Treatment

Zhuo-Li Zhang University of California, USA
3 14:54-15:06

Molecular Imaging Biomarker Development for Combined Immunotherapy and Locoregional Therapy of HCC: From Bench to Bedside

Julius Chapiro Yale School of Medicine, USA
4 15:06-15:18

Comprehensive TAE Strategy for HCC Based on Thermo-Sensitive Nanogels

Xiang-Liang Yang Huazhong University of Science and Technology, China
5 15:18-15:30

Towards Precision Medicine: Multi-modal Image Analysis Driven by Artificial Intelligence

Yang Wang Zhejiang Cancer Hospital, China
6 15:30-15:45

Panelists

Francis Lee Yale School of Medicine, USA / Rui-Fang Ni The First Affiliated Hospital of Soochow University, China / Ajit K. Yadav Sir Ganga Ram Hospital, Delhi, India / Zhuo-Li Zhang University of California, USA / Xiang-Liang Yang Huazhong University of Science and Technology, China / Julius Chapiro Yale School of Medicine, USA / Yang Wang Zhejiang Cancer Hospital, China
16:00-18:00 (UTC+8) | Tumor Ablation & Cryo-Thermal Techniques Symposium
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:10

Opening Remarks

Gao-Jun Teng Zhongda Hospital, Southeast University, China
2 16:10-16:25

Cryoablation for Locally Advanced Pancreatic Cancer and Pancreatic Metastasis

Alexey Zhao P. A. Herzen Institute of Oncology, Russia
3 16:25-16:40

Interventional Treatments for Benign and Malignant Breast Masses

Mehmet Mahir Atasoy Maltepe University School of Medicine, Turkey
4 16:40-16:55

Cryoablation in the Prostate

Saim Yilmaz Varisson Radiology Center, Turkey
5 16:55-17:10

The role of Thermal Ablation Methods in the Treatment of HCC in the Republic of Kazakhstan

Niyaz Malayev National Scientific Medical Center, Kazakhstan
6 17:10-17:25

Role of Interventional Radiology in Pain Management of Abdominal Cancer

Shahzad Bhatti Mayo Hospital/King Edward Medical University, Pakistan
7 17:25-17:40

Co-ablation System in Tumor Therapy: Advancements in Composite Cryo-thermal Ablation for Cancer Treatment

Li-Zhi Niu Guangzhou Fuda Cancer Hospital, China
8 17:40-17:55

Discussion

Wei-Jun Fan Sun Yat-sen University Cancer Center, China / Zhong-Min Wang Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
9 17:55-18:00

Conference Summary

Gao-Jun Teng Zhongda Hospital, Southeast University, China

Meeting Room M2 (UTC+8)

13:30-14:30 (UTC+8) | Precise and Intelligent Tumor Intervention Solutions
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:42

New Ice Age of Musculoskeletal Intervention: Role of Percutaneous Cryoablation in Bone and Soft Tissue Tumors

Jun-Jian Huang Emory University school of medicine, USA
2 13:42-13:54

Super-selective TACE

Seung Boo Yang Nowon Eulji University Hospital, Korea
3 13:54-14:06

Optimizing Outcomes in Centrally Located HCC: The Evolving Role of Precision Radiotherapy

Wei-Hu Wang Beijing Cancer Hospital, China
4 14:06-14:18

From Vision to Precision: Image-guided Solutions for Interventional Oncology

Yu Deuerling Zheng Siemens Healthineers, Germany
5 14:18-14:30

Panelists

Hai-Bin Shi Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China / Jun-Jian Huang Emory University school of medicine, USA / Seung Boo Yang Nowon Eulji University Hospital, Korea / Wei-Hu Wang Beijing Cancer Hospital, China / Yu Deuerling Zheng Siemens Healthineers, Germany
14:30-15:30 (UTC+8) | ThinkEmbolic @ ISMIO
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 14:30-14:45

Transradial HepaSphere Treatment for HCC in AMC

Ji Hoon Shin Asan Medical Cente, University of Ulsan College of Medicine, Korea
2 14:45-15:00

Combined Immuno-DTACE for Difficult-to-treat Liver Cancer Patients

Alex Tang Subang Jaya Medical Centre,Malaysia
3 15:00-15:15

Advancing Your Practice in Refractory Liver Cancers Management

Shinichi Hori Institute for Image Guided Therapy, Japan
4 15:15-15:30

Discussion

Jia-Ping Li The First Affiliated Hospital of Sun Yat-sen University, China / Zi-Shu Zhang Xiangya Hospital Central South University, China / Hai-Bo Shao The First Affiliated Hospital of China Meical University, China
16:00-18:00 (UTC+8) | Your Efforts Matter - Ⅳ
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 16:00-16:06

Does Needle Biopsy Immediately after Percutaneous Microwave and Cryoablation of Lung Neoplasm Affect Pathological Results? A Clinical and Animal Study

Jun-Ting Ma First Hospital of China Medical University, China
2 16:06-16:12

Outcomes of First-line Microwave Ablation of Treatment-naive Epidermal Growth Factor Receptor–mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors

Sheng Xu Beijing Hospital, National Center of Gerontology, China
3 16:12-16:18

Microwave Ablation versus Lobectomy for Ground-glass Opacity Nodules in the Hilar Region: A Multicenter Prospective Real-world Study on Efficacy and Safety

Jia-Chang Chi renji hospital, China
4 16:18-16:24

Cryoablation Enhanced Anti-tumor Immunity and Survival for Patients with Liver Metastatic Melanoma Receiving PD-1 Blockade Therapy: Insights from Longitudinal RNA-seq Data

Chen Li Sun Yat-sen University Cancer Center, China
5 16:24-16:30

Response Evaluation of Liver Directed Therapies for Liver Metastasis in NET

VARSHA KEDAR TATA MEMORIAL HOSPITAL, MUMBAI , INDIA
6 16:30-16:36

Hepatic Arterial Infusion Chemotherapy with or without Hepatic Artery Chemoembolization for Esophageal Carcinoma Patients with Liver Metastasis: A Clinical Retrospective Study

Mingrui Yan Peking University Shougang Hospital,Beijing, China
7 16:36-16:42

Drug Eluting Bead Transarterial Chemoembolization (DTACE) Combined with Hepatic Arterial Infusion Chemotherapy versus DTACE Alone for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer stage C: A Prospective, Multicenter Analysis

Daqian Han The First Affiliated Hospital of Zhengzhou University
8 16:42-16:48

Comparing Percutaneous and Endoscopic Biliary Drainage in Inoperable Bismuth III/IV Malignant Hilar Biliary Obstruction: Clinical Outcomes and Prognostic Factors

XIAO-BO FU Sun Yat-sen University Cancer Center, China
9 16:48-16:54

Metformin Suppress Liver Cancer Metastasis by Inhibiting Microwave Ablation Therapy Induced EMT through Modulation of the TGF-β-Smad2/3 Signaling Pathway

Xian-Mei Liu Affiliated Hospital of Guizhou Medical University, China
10 16:54-17:00

Health Economics Analysis of Three Treatment Methods for Uterine Fibroids

Yong Jin The Second Affiliated Hospital of Soochow University, China
11 17:00-17:06

Percutaneous Transhepatic Cholangiography in Biliary Obstruction: A Retrospective Audit of Outcomes and Complications

Sana Sheykhzadeh Norfolk and Norwich University Hospital
12 17:06-17:12

Retrospective Analysis of Diagnostic Accuracy of Image-guided Needle Biopsy of Pancreatic Lesions

Antariksh Vijan Tata Memorial Hospital, Mumbai, India
13 17:12-17:18

CCL2⁺ Inflammatory Cancer-associated Fibroblasts Promote Chemoresistance and Tumor Progression in Microsatellite Stable Colorectal Cancer via the CCL2-P4HB-NOTCH-STAT3 Axis

Si-Yuan Weng National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China
14 17:18-17:24

3D-printed Versatile Biodegradable Biliary Stent with Zinc/Sirolimus for Anti-bacterial and Anti-hyperplasia in a Rabbit Bile Duct

Jung-Hoon Park Asan Medical Center, Korea
15 17:24-17:30

Neoadjuvant Arterial Infusion Chemotherapy versus Intravenous Chemotherapy for Locally Advanced Gastric Cancer: A Long-term Follow-up

Jun Chen Zhejiang Provincial People's Hospital, Hangzhou Medical College, China
16 17:30-17:36

Whether the Choice of Location for Re-implantation Chest Port Affects the Incidence of Complications in Adult Tumor Patients Undergoing Right Chest Port Removal

Cao-Ye Wang Changzhou First People Hospital, China
17 17:36-17:42

Direct Percutaneous Embolization of Hypervascular Renal Cell Cancer Metastasis to the Spine

Calvin Cheong National University Hospital, Singapore
18 17:42-17:48

Long-term Outcomes of Image-guided Ablation and Laparoscopic Partial Nephrectomy for T1 Renal Cell Carcinoma

Vinson Chan University of Leeds, United Kingdom
19 17:48-17:54

The Status of Cytotoxic Lymphocytes Indicate Therapeutic Efficacy and Prognosis in Patients with Advanced Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Systemic Therapies

Hai-Feng Zhou The First Affiliated Hospital of Nanjing Medical University, China
20 17:54-18:00

Transjugular Intrahepatic Portosystemic Shunt Plus Transarterial Chemoembolization of Hepatocellular Carcinoma Patients with Portal Vein Tumour Thrombus-related Variceal Bleeding

Wei-Zhong Zhou The first affiliated hospital of Nanjing medical university, China

Meeting Room M6 (UTC+8)

13:30-17:30 (UTC+8) | ROADS Session
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:35

Welcome Address

Sheng-Hong Ju Zhongda Hospital, Southeast University, China
2 13:35-13:40

ROADS Launch Ceremony

3 13:40-14:05

How to Evaluate Treatment Response of HCC after Radiation Based Locoregional Treatment: LR-TRA v2024

Jeong Min Lee Seoul National University Hospital, Korea
4 14:05-14:30

Recent Advances in Image-Guided Locoregional Therapies for HCC (New Navigation Tools, New Devices, New Techniques)

Roberto Iezzi Università Cattolica del Sacro Cuore, Italy
5 14:30-14:55

MRI at 0.05 Tesla: A Computing-powered Point-of-care Imaging Device?

Ed X. Wu The University of Hong Kong, China
6 14:55-15:20

Use of EOB MRI for Imaging of Hepatic Malignancies

Cher Heng Tan Tan Tock Seng Hospital, Singapore
7 15:20-15:35

Coffee Break

8 15:35-16:00

Infiltrative HCC: What Every Radiologist Needs to Recognize and Report

Sahat Matondang Cipto Mangunkusumo National General Hospita, Indonesia
9 16:00-16:25

Hepatocellular Carcinoma beyond Diagnosis: Role of Imaging in Prognostication, Pathology and Genetic Correlation

Xiao-Yang Liu The University of Toronto, Canada
10 16:25-16:50

Imaging Evalution of the Treatment Response after Locoregional Therapy for HCC

Yuan-Cheng Wang Zhongda Hospital, Southeast University, China
11 16:50-17:30

ROADS Abdominal Imaging Case Review Webinar

Meeting Room M4 (UTC+8)

13:30-14:00 (UTC+8) | CR Innovation Forum
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 13:30-13:35

Opening Speakers

Gao-Jun Teng Zhongda Hospital, Southeast University, China / Masatoshi Kudo Kindai University Faculty of Medicine, Japan / Jian Zhou Zhongshan Hospital, Fudan University, China
2 13:35-13:40

ISMIO Meets APPLE: International Consensus Project on TACE Combined with Targeted Therapy and Immunotherapy for HCC

Gao-Jun Teng Zhongda Hospital, Southeast University, China / Masatoshi Kudo Kindai University Faculty of Medicine, Japan / Jian Zhou Zhongshan Hospital, Fudan University, China / Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China / Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China / Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China / Hong Wu West China Hospital of Sichuan University, China
3 13:40-14:00

Panel Discussion: CNLC Meets BCLC: Impact of TACE-Targeted-Immunotherapy Advances on International Guideline Updates: Evidence from Global Trials and Clinical Practice

Gao-Jun Teng Zhongda Hospital, Southeast University, China / Masatoshi Kudo Kindai University Faculty of Medicine, Japan / Jian Zhou Zhongshan Hospital, Fudan University, China / Lian-Xin Liu The First Affiliated Hospital of University of Science and Technology of China / Feng Shen Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China / Ming Kuang The First Affiliated Hospital, Sun Yat-Sen University, China / Hong Wu West China Hospital of Sichuan University, China

2025-06-08 Sunday

Exhibition Area II (UTC+8)

08:00-09:30 (UTC+8) | Thyroid Ablation
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 08:00-08:12

TBD

Dong Xu Zhejiang Cancer Hospital, China
2 08:12-08:24

TBD

Hui-Xiong Xu Zhongshan Hospital, Fudan University, Shanghai, China
3 08:24-08:36

Ablation of Papillary Microcacinoma

Mehmet Korkmaz Evliya Çelebi Training & Research Hospital, Turkey
4 08:36-08:48

Ablation of Parathyroid Adenomas

Furkan Erturk Urfali Bursa City Hospital, Turkey
5 08:48-09:00

Surgical Perspectives on Thyroid Anatomy and Strategies for Ablative Treatment of Benign and Malignant Tumors

Ying Zhou The First Affiliated Hospital of Hebei University of Chinese Medicine, China
6 09:00-09:12

The Role of URM in the Differential Diagnosis of Benign and Malignant Cervical Lymph Nodes: A Preliminary Study

Ji-Ye Chen Zhejiang Cancer Hospital, China
09:30-11:00 (UTC+8) | Your Efforts Matter - Ⅴ
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 09:30-09:36

Preparation of a Composite Nanozyme and Its Sonodynamic Therapy in Bladder Cancer

Jia-Jia Zheng Zhejiang Provincial People‘s Hospital, China
2 09:36-09:42

Trans-arterial Embolisation Prior to Image-guided Ablation for T1b/T2a Renal Masses – A Systematic Review and Meta-analysis

Aisha Ahmed University of Leeds
3 09:42-09:48

Multicentre Real World Outcomes of Irreversible Electroporation for Complex Small Kidney Cancers (REWIRED)

Vinson Chan University of Leeds, United Kingdom
4 09:48-09:54

Results of Ultrasound Guided Vacuum Assisted Breast Biopsy Treatment for Benign Breast Tumor

Batmunkh Erdenebulgan Second state central hospital, Mongolia
5 09:54-10:00

A Nomogram Predicting Venous Thromboembolism Risk in Primary Liver Cancer Patients

Jing Xiao Chongqing University Cancer Hospital, China
6 10:00-10:06

Breat Thermogram Database Generation to Use AI for Early Breast Cancer Detection

Bilal Majeed University of Limerick
7 10:06-10:12

Irradiation Modulates sEVs-PD-L1 Transport in TNBC's Tumor Immune Microenvironment

Yuqin Wei Wuming Hospital of Guangxi Medical University, China
8 10:12-10:18

A Real-world Survey of 1830 Surviving Patients with Adamantinomatous Craniopharyngioma in China

Zhi-Xiong Lin Sanbo Brain Hospital, Capital Medical University, China
9 10:18-10:24

The Diversity of Arterial Approaches in Delivering Intra-arterial Chemotherapy for Retinoblastoma: Experiences from Indonesia

Jason Jason Department of Radiology, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
10 10:24-10:30

Comparative Effectiveness of Liquid versus Solid Embolic Agents in Pre-surgical Embolization for Intracranial Tumors: A Systematic Review and Meta-analysis

Yuhang Zhao Zhongda Hospital, Medical School, Southeast University, China
11 10:30-10:36

Percutaneous Catheter Drainage (PCD) as Primary Treatment for Necrotizing Pancreatitis: Clinical Outcomes and Comparative Effectiveness

Gantulga Vanchinsuren Second State Center Hospital
12 10:36-10:42

Analysis of Short and Medium Term Clinical Effect of Prostatic Artery Embolization on Symptomatic Prostatic Hyperplasia

Shi-Long Han Tenth People's Hospital of Tongji University, China
13 10:42-10:48

Role of Sclerotherapy in Patients with Vascular Malformations - A Retrospective Study

Anand Agrawal
14 10:48-10:54

Single-cell RNA Sequencing Identifies the Versican-producing Cells in Tumor Microenvironment of Cervical Cancer

Meng-Fan Zhang First Affiliated Hospital of Zhengzhou University, China

Meeting Room M2 (UTC+8)

08:00-09:30 (UTC+8) | Your Efforts Matter - Ⅵ
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 08:00-08:06

CT-Guided Microwave Ablation with Vertebral Augmentation for Spinal Metastases with Posterior Wall Defects

Kai-Xian Zhang Tengzhou Central People’s Hospital, China
2 08:06-08:12

A Novel Silver Nanoparticles-functionalized Stent for the Treatment of Malignant Stricture of Esophagus

Yan Fu National cancer hospital, Beijing, China
3 08:12-08:18

Mitochondrial-Cytosolic Cascade Metabolic Regulation System: A Robust Strategy to Disrupt Multipath Energy Replenishment in Cancer Therapy

Tian-Ming Wang Xiangya Hospital, Central South University, China
4 08:18-08:24

Prevention of Acute Thrombosis with Vascular Endothelium Antioxidative Nanoscavenger

Yi-Xin Zhong Southeast University Affiliated Zhongda Hospital, China
5 08:24-08:30

Idarubicin-loaded Degradable Hydrogel for TACE Therapy Enhances Anti-tumor Immunity in Hepatocellular Carcinoma

Xiao-Kai Zhang Henan Cancer Hospital/ Affiliated Cancer Hospital of Zhengzhou University, China
6 08:30-08:36

The Eight Mitochondrial Metabolism-related Genes as Diagnostic Markers for Abdominal Aortic Aneurysm by Integrating Machine Learning Approach

Yang Zheng Chongqing University Cancer Hospital
7 08:36-08:42

Functionalized Calcium Alginate Microspheres for TACE Immunotherapy via Polarizing Macrophages and Releasing Anti-tumor Immune Exosomes

Xiao-Ju Guo Lishui Central Hospital, China
8 08:42-08:48

Celecoxib and Cisplatin Dual-loaded Microspheres Synergistically Enhance Transarterial Chemoembolization Effect of Hepatocellular Carcinoma

Xin-Wei Han The First Affiliated Hospital of Zhengzhou University, China
9 08:48-08:54

Synergistic Quad-modal Nanoembolics: pH/NIR-Driven Chemo-photothermal Ablation with Immune Reprogramming for HCC

Wan-Qing Shen the first affiliated hospital of sun yat-sen university, China
10 08:54-09:00

Restraining Small Extracellular Vesicles: Dawn of A New Era in Nanomedicine

Ming Yang Zhongda Hospital, Southeast University, China
11 09:00-09:06

Engineered Macrophage Membrane-mimicking Nanodrugs Activate the cGAS/STING Pathway to Reverse the Immune-suppressive Microenvironment Induced by RFA

Wei-Hua Zhang Southeast University, China
12 09:06-09:12

Development and Functional Research of an Irradiation-cytokine Composite Stent for Modulating Immune Microenvironment Reprogramming

Juan Qin Zhongda Hospital, Medical School, Southeast University, China
13 09:12-09:18

Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation-induced Tumor Relapse by Reprogramming Antitumor Immunity

Duo Wang zhongda hospital, southeast university, China
14 09:18-09:24

Autocatalytic Pyroptosis Agonists Modulate Tumor Metabolism and Enhance TACE Efficacy in HCC Therapy

Lin-Zhu Zhang Zhongda Hospiital, Southeast University, China
15 09:24-09:30

Injectable Hydroxyapatite Radiopaque Microspheres: The Next-generation Material for Cancer Interventional Embolization?

Yi-Nan Ding sciences zhejiang cancer hospital, China
09:30-11:00 (UTC+8) | Your Efforts Matter - Ⅶ
NO. Beijing Time (UTC+8) Presentation Topic Speaker Affiliation / Organization
1 09:30-09:36

First-in-Human Study of an Artificial Intelligence Integrated Robot for Image-Guided, Trans-Thoracic Lung Biopsy under Local Anaesthesia

Nadia Rojas Singapore General Hospital, Singapore
2 09:36-09:42

Cancer-Associated Fibroblasts-Derived SEMA3C Facilitates Colorectal Cancer Liver Metastasis via NRP2-Mediated MAPK Activation.

Yuyuan Zhang The First Affiliated Hospital of Zhengzhou University, China
3 09:42-09:48

Global Interest of Interventional Radiology and Interventional Oncology: A Review of a Decade Using The Google Trends Platform

Vinson Chan University of Leeds, United Kingdom
4 09:48-09:54

Quantification of Habitat Imaging Combined with Peritumoral Microenvironment Evolution for Predicting Extracapsular Extension in Prostatic Cancer

Ye Xiang Leshan Hospital,Chengdu University of TCM, China
5 09:54-10:00

Harmonizing Ancient Wisdom and Modern Technology: Exploring Retrieval-Augmented Generation (RAG) with Large Language Models to Transform Education in Interventional Oncology

Hassan Magdy Gastrointestinal Surgery Center, Mansoura University, Egypt
6 10:00-10:06

Conventional Oral Morphine vs. IV Patient-Controlled Analgesia (IPCA) with Hydromorphone (HM) Continuous Infusion plus Rescue Dose (CIRD) or Bolus-Only (BO) for Severe Cancer Pain: A Randomized Phase III study

Liyu Su Fujian Cancer Hospital, China
7 10:06-10:12

Efficacy Comparison of Liver Venous Deprivation and TACE Combined with Targeted and Immunotherapies in Unresectable Hepatocellular Carcinoma with Insufficient FLR Volume

Ying Yang West China Hospital, Sichuan University, China
8 10:12-10:18

Spatial Transcriptomics Reveals Tryptophan Metabolism Restricting Maturation of Intratumoral Tertiary Lymphoid Structures

Shuling Chen The First Affiliated Hospital of Sun Yat-sen University, China